Search results (10)
« Back to NewsNew research identifies autoimmunity against a key anti-inflammatory regulator in inflammatory bowel disease
4 August 2024
- Clinical Trials
- Department
- Gastroenterology
- Immunology
- Publication
- Research
- Research Methods
- University
A ground-breaking study, published by the New England Journal of Medicine, has identified a new disease-inducing mechanism for inflammatory bowel disease (IBD) in which the immune system attacks its own regulatory function.
First in-human vaccine trial for Nipah virus
11 January 2024
The University of Oxford has launched a new clinical trial to test a vaccine against the deadly Nipah virus.
Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines
25 October 2023
A pioneering study into human immunity is being launched today by Oxford Vaccine Group at the University of Oxford. The study, called LEGACY03, is being funded by the Medical Research Council part of UK Research and Innovation. By investigating how lymph nodes work, and how they make responses to vaccines in younger and older people, it has the potential to improve vaccine design for different age groups significantly.
First vaccine trial in older people launched for Middle East Respiratory Syndrome (MERS)
18 September 2023
Researchers at the University of Oxford's Pandemic Sciences Institute have launched a new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS).
Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment
16 May 2022
A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.
New atlas revealed of bone marrow haematopoiesis during development
5 October 2021
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
Paul Riley appointed Director of Oxford’s Institute of Developmental and Regenerative Medicine
11 October 2020
Professor Paul Riley will lead the scientific vision of the first institute of its kind in the world to physically merge the disciplines of developmental biology and regenerative medicine in a common goal to treat some of the world’s most prolific diseases.
IDRM ground-breaking – work gets underway!
14 January 2020
Work will shortly be underway on the new IMS-Tetsuya Nakamura Building, home to the new Institute of Developmental and Regenerative Medicine at Old Road Campus. The formal ground-breaking ceremony, which took place towards the end of last year, was organised by the Department of Paediatrics in collaboration with the Medical Sciences Development team.
When art and science meet
30 November 2016
Annina Grädel works together with painter-printmaker and video-artist to create an artwork that reflects T-cells in the thymus
Study suggests routes to improved immunity in older people
22 August 2016
A study from Oxford and Basel universities may point the way to maintaining our immune systems as we get older.